TNF and postmenopausal osteoporosis: Further, the present finding strongly suggests that the antiosteoporotic activity of AKBA may be mediated through its inhibition of the NF-κB-induced TNF-α signaling pathway, which consequently substantiates its possible use in the management of postmenopausal osteoporosis.